mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On August 7, 2017, during aftermarket hours, Depomed Inc. announced that it had received a request for information relating to the promotion of opioids from the U.S. Senate Committee on Homeland Security and Governmental Affairs, as well as from the Office of the Attorney General of Maryland and the U.S. Department of Justice.

On August 18, 2017, a securities class action lawsuit was filed against Depomed Inc. over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that Depomed engaged in questionable practices in connection with the sales and marketing of the Company's opioid products, that the foregoing conduct, when it became known, would likely subject the Company to heightened legal and regulatory scrutiny, and that as a result, Depomed's public statements were materially false and misleading at all relevant times.

Those who purchased Depomed Inc. (NASDAQ: DEPO) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 475752

"/> Lawsuit for Investors in Depomed Inc. (NASDAQ: DEPO) Shares Announced by Shareholders Foundation « MarketersMedia – Press Release Distribution Services – News Release Distribution Services
MarketersMEDIA Year End Sale is Finally Back! Get up to 70% OFF on your press releases. Hurry! Limited time only.
Click Here
How It Works? Plans & Pricing Our Distributions Newsroom Info Hub Sign Up Sign In Send Press Release Contact Sales
Contact Sales Sign Up Your Account Send Press Release
MarketersMEDIA / Newsroom / Lawsuit for Investors in Depomed Inc. (NASDAQ: DEPO) Shares Announced by Shareholders Foundation

Lawsuit for Investors in Depomed Inc. (NASDAQ: DEPO) Shares Announced by Shareholders Foundation

Share This Press Release

SAN DIEGO, CA / ACCESSWIRE / September 25, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for investors who purchased NASDAQ: DEPO shares against Depomed Inc. over alleged Securities Laws Violations in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Depomed Inc. (NASDAQ: DEPO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On August 7, 2017, during aftermarket hours, Depomed Inc. announced that it had received a request for information relating to the promotion of opioids from the U.S. Senate Committee on Homeland Security and Governmental Affairs, as well as from the Office of the Attorney General of Maryland and the U.S. Department of Justice.

On August 18, 2017, a securities class action lawsuit was filed against Depomed Inc. over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that Depomed engaged in questionable practices in connection with the sales and marketing of the Company's opioid products, that the foregoing conduct, when it became known, would likely subject the Company to heightened legal and regulatory scrutiny, and that as a result, Depomed's public statements were materially false and misleading at all relevant times.

Those who purchased Depomed Inc. (NASDAQ: DEPO) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 475752

SAN DIEGO, CA / ACCESSWIRE / September 25, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for investors who purchased NASDAQ: DEPO shares against Depomed Inc. over alleged Securities Laws Violations in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Depomed Inc. (NASDAQ: DEPO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On August 7, 2017, during aftermarket hours, Depomed Inc. announced that it had received a request for information relating to the promotion of opioids from the U.S. Senate Committee on Homeland Security and Governmental Affairs, as well as from the Office of the Attorney General of Maryland and the U.S. Department of Justice.

On August 18, 2017, a securities class action lawsuit was filed against Depomed Inc. over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that Depomed engaged in questionable practices in connection with the sales and marketing of the Company's opioid products, that the foregoing conduct, when it became known, would likely subject the Company to heightened legal and regulatory scrutiny, and that as a result, Depomed's public statements were materially false and misleading at all relevant times.

Those who purchased Depomed Inc. (NASDAQ: DEPO) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 475752

Source URL: https://marketersmedia.com/lawsuit-for-investors-in-depomed-inc-nasdaq-depo-shares-announced-by-shareholders-foundation/242923

Source: AccessWire

Release ID: 242923

Our Client

Subscribe and Recieve exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2017 MarketersMedia – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).